/

GZI Industries Translates Science into Finance for Higher Returns and Less Volatility

Introduction

Are you tired of low returns and high market volatility? Look no further than GZI Industries, a synthetic finance startup that leverages biotechnology and cleantech trading on international exchanges to provide users with cutting-edge alternative data for higher returns and less volatility.

Launched at the Founder Institute, the world’s largest pre-seed accelerator, GZI is at the forefront of translating scientific innovation into financial technology. Here’s a closer look at what sets this startup apart:

Revolutionary Approach to Investing

GZI is the first to use biotechnology and cleantech trading to pioneer synthetic finance. By repackaging global knowledge of the new normal into alternative data, GZI provides users with higher returns and reduced volatility in a market where traditional methods often fail.

Impressive Track Record

GZI’s data produced over 400% returns on biotechnology companies in 2020, with a mark-to-market gain of 58% and IRR of 60%. Back-tested data projects outperformance of indexes by 30-73%. And in 2021, the company has already achieved a mark-to-market of 30%.

Top-Tier Affiliations

GZI is an FI Select company, which places it in the top 2% of its portfolio of over 5,000 companies across the globe. Other notable FI companies include Udemy and Thumbtack.

Invest in GZI

If you’re ready to experience higher returns and less volatility, consider investing in GZI. Visit their website to learn more about the company and access their platform. With a revolutionary approach to investing, an impressive track record, and top-tier affiliations, GZI Industries is a startup to watch in the world of synthetic finance.

Read more from US Venture News  The Retail Technology Revolution in San Francisco - Exploring Innovative Startups

Website: https://gzi.app/
LinkedIn: https://www.linkedin.com/company/gzi
Investment Link: https://bit.ly/gzixnetcapital


Ready to amplify your reach and engage with the most dynamic community in the venture world? Consider sponsoring an article with us. Learn more about our promotional opportunities and sponsored articles here.

Your story could be the next big hit on US Venture News!

Read more from US Venture News  Flare Therapeutics - Deciphering the Biology of Transcription Factors to Develop Small Molecule Medicines
Previous Story

Prime Web Developers Revolutionizing Web Development Services

Next Story

Hubbub Industries – Eliminating Urban Consumer Waste, One Rental at a Time

Follow Us